Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

NCT03230786 is registered in ClinicalTrials.gov with KeyBioscience AG as lead sponsor.

NCT NCT03230786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes
Lead sponsor
KeyBioscience AG
Phase
Phase 2
Overall status
Completed
Start date
August 23, 2017
Completion date
July 31, 2018
Enrollment
255 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus